AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Right arrow Help viewing high resolution images
Right arrow Return to article

[View Larger Version of this Image (79K JPEG file)]

FIG. 2.   Inactivation of CRPV by SDS and comparison with inactivation by N-9. Aliquots of CRPV (10-2 dilution) were mixed with concentrated SDS or concentrated N-9 to a final concentration of 0.05% as described in Materials and Methods. Untreated virus (open circle ) or treated virus (bullet ) was inoculated at two sites each per animal, and papilloma production was measured as the GMD of visible lesions on the indicated days. (a) Comparison of results for 10 SDS-treated and 10 untreated virus inoculation sites. (b) Comparison of 10 N-9-treated and 10 untreated virus inoculation sites. Papilloma production was measured as the average GMD of visible lesions on the indicated days.




Right arrow Return to article


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS